TrimRx
United States
Revenue Intelligence
Verified performance metrics directly from the source.
Verified MRR
$289k
▼ 62.5%
$3.5M
$11.6M
0
AI Risk Assessment
This startup has a ProvenMRR Health Score of 77/100, reflecting strong fundamentals with consistent revenue and healthy growth. Monthly Recurring Revenue stands at $712,208, trending down 7.8% month-over-month. Churn is exceptionally low, indicating strong product-market fit. With 0 active customers and a revenue volatility index of 0.0, the business demonstrates investor-grade predictability. [AI insights powered by ProvenMRR — advanced analysis available in Premium]
Diagnostics
Revenue Trajectory
Founder
Startup insights
Value Proposition
TrimRx is a telehealth company that specializes in personalized weight loss programs using GLP-1 medications like Semaglutide and Tirzepatide. With licensed medical providers, FDA-registered pharmacie
Problem Solved
TrimRx is a telehealth company that specializes in personalized weight loss programs using GLP-1 medications like Semaglutide and Tirzepatide. With licensed medical providers, FDA-registered pharmacies, and a focus on safety, effectiveness, and ongoing support, TrimRx has helped thousands of clients across the U.S. achieve their weight loss goals.
Business Details
Software/SaaS
